Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ), a leading U.S. cannabis company known for its branded product portfolio and Sunnyside dispensaries, has announced it will report third-quarter 2026 financial results before market open on Friday, November 6, 2026. The company will simultaneously host an earnings conference call and live webcast at 8:30 a.m. ET to discuss the results and provide business highlights. Investors in the Canadian-listed cannabis sector will be watching the release for signals on Cresco's operational and financial trajectory through the third quarter ended September 30, 2026.

Key Points

  • Cresco Labs Inc. (CSE: CL, OTCQX: CRLBF, FSE: 6CQ) is a Chicago-based multi-state cannabis operator
  • The company will release Q3 2026 financial results before market open on November 6, 2026
  • An earnings conference call and webcast are scheduled for 8:30 a.m. ET on November 6, 2026; archived webcast access will be available for one year
  • Investors will be watching Q3 revenue, margins, and brand performance across Cresco's national portfolio

Cresco Labs Sets November 6 Date for Third-Quarter Earnings Disclosure

Cresco Labs confirmed via a release dated October 15, 2026, that it will publish its financial results for the three-month period ended September 30, 2026, before North American equity markets open on November 6. The company described itself as an industry leader in branded cannabis products and operator of Sunnyside dispensaries. No preliminary financial figures, revenue guidance, or earnings estimates were included in the announcement. The immediate share price impact was not clear from available public information.

Earnings Webcast and Conference Call Details for Q3 2026

Alongside the financial release, Cresco Labs will host a live conference call and webcast on November 6, 2026, beginning at 8:30 a.m. Eastern Time. The event is intended to give investors and analysts an opportunity to review third-quarter results and hear key business highlights directly from management. The company states that archived access to the webcast will remain available for one year on its investor relations website. No dial-in number or additional access details were included in the announcement beyond a webcast registration link.

Cresco's Brand Portfolio and National Cannabis Strategy

Cresco Labs describes its business model as applying a consumer-packaged-goods approach to cannabis, building national brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy's, and Remedi. The company also operates its Sunnyside retail dispensary brand nationally, with a stated focus on consumer education and trust. The announcement did not provide updated store counts, production volumes, or brand-level revenue figures. Investors may be watching the November 6 results for insight into how these brand and retail strategies are performing across U.S. markets.